Livermore

TRV GP V, LLC

SEC CIK
0001990717

Holdings, Q2 2026

Positions as of Jun 30, 2026, filed Aug 7, 2026.SEC

Positions
3
0 vs. Q1 2026
Total value
$498.24M
+$97.24M (+24.2%) vs. Q1 2026

Compare with Q1 2026: new, added, reduced and sold out

Positions

Long positions only. Changes compare share counts with Q1 2026.

TRV GP V, LLC holdings in Q2 2026
SecurityClassSharesValue% of portfolioChange in sharesActionHistory
RAPPRAPPORT THERAPEUTICS INCCOM6,280,525$261.71M52.53%−854,708−12.0%ReducedView
SEPNSEPTERNA INCCOM6,215,591$208.16M41.78%00.0%UnchangedView
MAZEMAZE THERAPEUTICS INCCOM950,800$28.37M5.69%00.0%UnchangedView

13F filings by quarter

TRV GP V, LLC 13F filings by quarter
QuarterFiledPositionsTotal valueChangesFiling
Q2 2026Aug 7, 20263$498.24Mvs. Q1 2026SEC
Q1 2026May 7, 20263$401Mvs. Q4 2025SEC
Q4 2025Feb 13, 20263$429.17Mvs. Q3 2025SEC
Q3 2025Nov 13, 20253$353.49Mvs. Q2 2025SEC
Q2 2025Aug 8, 20254$165.65Mvs. Q1 2025SEC
Q1 2025May 9, 20254$125.09Mvs. Q4 2024SEC
Q4 2024Feb 13, 20253$293.97M–SEC